Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs KraneShares Hang Seng TECH Index ETF (KTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs KraneShares Hang Seng TECH Index ETF — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while KraneShares Hang Seng TECH Index ETF trades at $11.52 (market cap $45.87M). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 87.6× KraneShares Hang Seng TECH Index ETF's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and KraneShares Hang Seng TECH Index ETF for 44 Days on average.
| EWTX | KTEC | |
|---|---|---|
Market Cap | $4.02B | $45.87M |
Volume | 1,446,128 | 30,098 |
Sector | Health | Sector/Thematic |
52-Week High | $48.35 | $18.36 |
52-Week Low | $14.89 | $11.41 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $3.56B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KTEC trades at $11.61 with no recent price movement. The stock shows bearish technical signals with 15 sell indicators versus 2 buy signals. Fundamentally, the company reported $120.04M revenue in 2016 with a net loss of $697K, though cash flow improved to positive $2.77M. Recent news highlights China's AI competition potentially benefiting tech ETFs like KTEC.
KTEC faces mixed prospects with improving cash flow but inconsistent profitability. The bearish technical outlook and volatile earnings history suggest caution, though exposure to AI sector growth through ETF positioning offers potential upside. Key risks include competitive pressures and execution challenges in maintaining positive momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About KraneShares Hang Seng TECH Index ETF
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →
